Brachyury/Bry Antibody [B3G11]

Catalog No.: F0979

    Application: Reactivity:
    • Lane 1: NCI-H460
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:1000
    1:8000
    1:1000
    1:400
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    47 kDa 43 kDa,49 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Brachyury/Bry Antibody [B3G11] detects endogenous levels of total Brachyury/Bry protein.
    Clone
    B3G11
    Synonym(s)
    TBXT, T-box transcription factor T, Brachyury protein, Protein T
    Background
    Brachyury (Bry, T) is an evolutionarily conserved T-box transcription factor that defines posterior mesoderm and notochord identity and integrates multiple developmental signaling pathways with lineage-specific gene programs in early embryos and notochord-derived tissues. The protein contains an N‑terminal T‑box DNA-binding domain that recognizes a palindromic T-site motif and a C‑terminal transactivation region that recruits transcriptional machinery and cofactors to activate target genes involved in mesoderm specification, morphogenetic movement, and axial elongation. During gastrulation, Brachyury expression at the primitive streak and along the forming axis marks progenitors that contribute to axial and paraxial mesoderm, and genome-wide binding maps define direct regulation of genes controlling cell motility, extracellular matrix organization, and cytoskeletal remodeling, linking this factor to coordinated tissue movements and germ layer patterning. Transcriptional network analysis positions Brachyury as a central activator that connects developmental signaling inputs to downstream regulators of hematopoietic, muscle, and endoderm-related fates, and integrates into feedback loops with Foxa2 and Sox17 that align lineage commitment with streak formation and axial extension. Upstream, Brachyury expression responds to gradients of morphogens such as Wnt and BMP that define posterior identity, while downstream targets encompass growth factors, adhesion molecules, and matrix components that shape cell migration paths, cohesion, and compartment boundaries in the emerging mesoderm. Brachyury maintains extracellular matrix homeostasis by binding a defined motif in the Smad3 promoter, increasing Smad3 transcription and protein abundance, and thereby supporting Smad3 phosphorylation and TGF‑β–Smad3–dependent expression of collagen II and aggrecan, which stabilizes disc matrix structure. This axis places Brachyury as a transcriptional relay between TGF‑β signaling and matrix gene expression in nucleus pulposus, with its reduced expression correlating with impaired matrix synthesis and disc degeneration phenotypes. Structural organization of the T‑box domain supports sequence-specific DNA recognition and dimerization properties shared across the T‑box family, while the variable C‑terminal portion encodes context-dependent regulatory motifs that adjust transactivation strength across embryonic and postnatal tissues. In human disease, persistent or ectopic Brachyury expression characterizes notochordal tumors such as chordoma and also appears in subsets of carcinomas, where its developmental roles in motility and matrix regulation align with epithelial–mesenchymal transition features, invasive behavior, and cancer stem-like traits described in mechanistic tumor-focused literature.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください